5 февр. 2024 г. · Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 billion on an enterprise value basis.

3 нояб. 2024 г. · Catalent was recently acquired by Novo Holdings for $16.5 billion. This deal is slated to close later in 2024.

8 февр. 2024 г. · Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5bn on an enterprise value basis.

30 окт. 2024 г. · When Novo Nordisk's holding company announced plans to acquire contract manufacturer Catalent for $16.5 billion in February, the deal faced ...

4 нояб. 2024 г. · The $16.5 billion acquisition, announced in February, underscores Danish drugmaker Novo Nordisk's push to boost output of its popular obesity ...

11 окт. 2024 г. · Under the deal, Novo Nordisk plans to take three of Catalent's manufacturing sites to bolster production of its blockbuster diabetes drug ...

Catalent has entered into an agreement to be acquired by Novo Holdings, a global investment firm focused on life sciences.

23 окт. 2024 г. · Under the current plan, Novo Nordisk is in line to purchase three Catalent fill-finish facilities from Novo Holdings for $11 billion after the ...

21 окт. 2024 г. · Catalent's acquisition by Novo Holdings is expected to close towards the end of calendar year 2024, subject to customary closing conditions.

20 февр. 2024 г. · Novo Nordisk is set to acquire three manufacturing facilities from contract development and manufacturing organization Catalent, in a bold move ...